- Home
- DNTH vs HUN Comparison
DNTH vs HUN Comparison
Compare DNTH & HUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DNTH | HUN |
|---|---|---|
| Founded | 2015 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.8B |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | DNTH | HUN |
|---|---|---|
| Price | $44.15 | $10.39 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 11 |
| Target Price | ★ $68.00 | $10.00 |
| AVG Volume (30 Days) | 756.1K | ★ 6.1M |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 9.92% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $3,078,000.00 | ★ $5,780,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.44 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.37 | $7.30 |
| 52 Week High | $44.95 | $20.94 |
Technical Indicators
Market Signals| Indicator | DNTH | HUN |
|---|---|---|
| Relative Strength Index (RSI) | 70.70 | 70.22 |
| Support Level | $39.82 | $8.04 |
| Resistance Level | $44.95 | $8.97 |
| Average True Range (ATR) | 2.47 | 0.47 |
| MACD | 0.56 | 0.25 |
| Stochastic Oscillator | 92.31 | 98.75 |
Price Performance
Historical ComparisonAbout DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About HUN Huntsman Corporation
Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. Its product portfolio comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, among others. Its operating segments are Polyurethanes, Performance Products, and Materials. It derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.